Related Articles
RAB6C is an independent prognostic factor of estrogen receptor‑positive/progesterone receptor‑negative breast cancer
High plasma YKL-40 level in patients with ovarian cancer stage III is related to shorter survival
Ki-67 as an independent prognostic factor in an unselected cohort of patients with ovarian cancer: Results of an explorative, retrospective study
Low RAB6C expression is a predictor of tamoxifen benefit in estrogen receptor‑positive/progesterone receptor‑negative breast cancer
Estrogen receptor and progesterone receptor are prognostic factors in soft tissue sarcomas